4DMedical Ltd.ASX: 4DX

Appendix 4D and FY26 Half Year Report

· Issued by 4DMedical Ltd.

Filed with ASX · · 28 pages · English

Summary by 6ix AI

The report highlights key operational achievements, including FDA clearance for the CT:VQ™ technology and significant growth in SaaS revenue and operational metrics. It also notes a substantial institutional placement to support commercialization efforts and expansion into new markets. The report indicates no dividends were declared during this period, and it includes a qualified auditor's opinion regarding goodwill and intangible assets.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

4DMedical Ltd. on 6ix

Story so far

Earlier from 4DMedical

Later from 4DMedical

All 4DMedical news releases